Characteristics of Non Diabetic Hyperglycemic Inpatients

September 25, 2023 updated by: Yannis Guerra, Cook County Health

Hyperglycemic Non Diabetic (HND) Hospital Patients: Are They Different From Diabetic Hyperglycemic and Non-Hyperglycemic Non-Diabetic(NHND) Patients?

Retrospective nested non-matched case control study comparing patients by glycemic status

Study Overview

Status

Completed

Conditions

Detailed Description

This retrospective nested non-matched case control study compared patients directly admitted to the General Medicine Wards, not transferred from ICU with

  • hyperglycemia on admission but no previous diagnosis of diabetes
  • diabetic hyperglycemic patients
  • non hyperglycemic non diabetic patients from the same nested population.

The investigators' hypothesis is that the clinical characteristics and endpoints of the non diabetic hyperglycemics should be similar to the diabetic population and different from the non diabetic non hyperglycemic population.

Study Type

Observational

Enrollment (Actual)

600

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Illinois
      • Chicago, Illinois, United States, 60612
        • John H. Stroger Jr. Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Nested sample obtained from patients admitted to John H. Stroger Jr. Hospital from March-April 2006 and in October 2007.

Description

Inclusion Criteria:

  • Admitted to John H. Stroger Jr. Hospital
  • Admitted to Internal Medicine Service from March-April 2006 and in October 2007

Exclusion Criteria:

  • Transfer from any intensive care unit (medical or surgical)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Hyperglycemic without previous DM diagnosis
Patients with hyperglycemia, without previous diagnosis of diabetes
Previous diagnosis of DM
Patients that have previous diagnosis of Diabetes Mellitus
No previous DM diagnosis and no hyperglycemia
Patient with NO previous diagnosis of diabetes, and no hyperglycemia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of stay
Time Frame: Measured 24 hours after patient is discharged. From day 1 of admission until day of discharge
Hospital stay measured in days
Measured 24 hours after patient is discharged. From day 1 of admission until day of discharge
Inpatient Mortality
Time Frame: From day 1 of admission until day of discharge
Mortality measured in number of events
From day 1 of admission until day of discharge

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of SIRS on admission
Time Frame: Measures obtained 24 hours after patient is discharged. Clinical data obtained on day 1 of admission
Number of SIRS
Measures obtained 24 hours after patient is discharged. Clinical data obtained on day 1 of admission
Frequency of inpatient infection
Time Frame: From day 1 of admission until day of discharge
Measured in number of events
From day 1 of admission until day of discharge
Rate of use of intravenous glucose drip
Time Frame: From day 1 of admission until day of discharge
Rate of use
From day 1 of admission until day of discharge
Frequency of steroid use
Time Frame: From day 1 of admission until day of discharge
Frequency of use
From day 1 of admission until day of discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cook County Health

Investigators

  • Principal Investigator: Evelyn Lacuesta, MD, John H. Stroger Jr. Hospital
  • Study Chair: Jyothsna Palla, MD, John H. Stroger Jr. Hospital
  • Study Chair: Yannis Guerra, MD, Rush University Hospital, John H. Stroger Jr. Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2006

Primary Completion (Actual)

December 1, 2007

Study Completion (Actual)

December 1, 2008

Study Registration Dates

First Submitted

February 11, 2009

First Submitted That Met QC Criteria

February 11, 2009

First Posted (Estimated)

February 12, 2009

Study Record Updates

Last Update Posted (Actual)

September 28, 2023

Last Update Submitted That Met QC Criteria

September 25, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 06-063

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe